Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Efficacy of Double Dose Oral Terbinafine Versus Itraconazole in Treatment of Dermatophyte Infections of Skin - A Prospective, Randomized Controlled Trial

NCT04880980 is registered in ClinicalTrials.gov with Pak Emirates Military Hospital as lead sponsor.

NCT NCT04880980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04880980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Efficacy of Double Dose Oral Terbinafine Versus Itraconazole in Treatment of Dermatophyte Infections of Skin - A Prospective, Randomized Controlled Trial
Lead sponsor
Pak Emirates Military Hospital
Phase
Phase 3
Overall status
Completed
Start date
March 15, 2021
Completion date
March 15, 2022
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dermatophyte infection, itraconazole adverse reaction, terbinafine adverse reaction